[go: up one dir, main page]

Mitchell, 2013 - Google Patents

William S. Bowen*, Siva K. Gandhapudi*, Joseph P. Kolb*, Thomas C. Mitchell

Mitchell, 2013

View PDF
Document ID
4204934999698524684
Author
Mitchell T
Publication year

External Links

Snippet

The structural core of bacterial lipopolysaccharide, lipid A, has played a role in medicine since the 1890s when William Coley sought to harness its immunostimulatory properties in the form of a crude bacterial extract. Recent decades have brought remarkable clarity to the …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Akdis et al. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens
Ben-Sasson et al. IL-1β strikingly enhances antigen-driven CD4 and CD8 T-cell responses
Geddes et al. Unleashing the therapeutic potential of NOD-like receptors
Pott et al. Innate immune signalling at the intestinal epithelium in homeostasis and disease
Woodfolk et al. Allergens, sources, particles, and molecules: Why do we make IgE responses?
Zhou The new face of anaphylatoxins in immune regulation
JP5730862B2 (en) Oklobactrum intermedium lipopolysaccharides and their use as mammalian immunostimulants
JP2006265212A (en) IL-21 production inducer
Amati et al. Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization
Mu et al. Schistosome infection and schistosome-derived products as modulators for the prevention and alleviation of immunological disorders
Jeong et al. Invariant natural killer T cells in lung diseases
WO2010068680A1 (en) Thelper cell type 17 lineage-specific adjuvants, compositions and methods
Schröder The role of innate immunity in the pathogenesis of asthma
US20210317218A1 (en) Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor
Akdis New insights into mechanisms of immunoregulation in 2007
Mitchell William S. Bowen*, Siva K. Gandhapudi*, Joseph P. Kolb*, Thomas C. Mitchell
Sprong et al. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production
Zheng et al. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance
Savoy et al. Synthetic triacylated lipid A derivative activates antigen presenting cells via the TLR4 pathway and promotes antigen-specific responses in vivo
Budiarti et al. Does the production of NF-ĸβ, IRF3, and IFN-β after LOS/LPS exposures in naive-HIV dendritic cells depend on TLR4-MD2 receptor pathway? In vitro and in silico study
Sun The mechanism of Alcaligenes Lipid A as a potent
Jennings-Gee et al. B cell-expressed CD1d promotes MPL/TDCM lipid emulsion adjuvant effects in polysaccharide vaccines
Bischoff et al. The Immunological Basis of IgE‐Mediated Reactions
Garden A Clinician's Guide to the Immune System: Innate and Adaptive Immunity
Alwethaynani Exploiting the potential of iNKT cells to improve vaccination